| 01.05 15:47 | dpa-AFX: *PERRIGO COMPANY PLC (PRGO) DECLARES QUARTERLY DIVIDEND OF $ 0.276, RECORD DATE 5/31/2024 |
| 01.05 15:44 | dpa-AFX: *PERRIGO DECLARES QUARTERLY DIVIDEND OF $0.276/SHR; PAYABLE JUNE 18/ RECORD MAY 31 |
| 25.04 12:35 | dpa-AFX: Esteve Healthcare To Buy Perrigo's HRA Pharma Rare Diseases Business For Up To EUR 275 Mln |
| 25.04 12:02 | dpa-AFX: *PERRIGO SEES HRA PHARMA RARE DISEASES BUSINESS TRANSACTION TO CLOSE DURING Q3 OF 2024 |
| 25.04 12:01 | dpa-AFX: *PERRIGO RECEIVES BINDING OFFER TO DIVEST HRA PHARMA RARE DISEASES BUSINESS FOR UP TO EUR 275 MLN |
| 04.03 14:47 | dpa-AFX: Perrigo Initiates Shipments Of Opill To Retailers Nationwide |
| 04.03 14:03 | dpa-AFX: *PERRIGO COMMENCES SHIPMENTS OF OPILL TO RETAILERS NATIONWIDE |
| 27.02 14:14 | dpa-AFX: ROUNDUP: Perrigo Launches Project Energize To Improve Efficiency, Cut Costs; To Cut 6% Jobs |
| 27.02 13:31 | dpa-AFX: Perrigo Q4 23 Earnings Conference Call At 8:30 AM ET |
| 27.02 12:48 | dpa-AFX: ROUNDUP: Perrigo Guides FY24 Well Below Estimates |
| 27.02 12:39 | dpa-AFX: *PERRIGO LAUNCHES INVESTMENT & EFFICIENCY PROGRAM; EXPECTS TO DELIVER ANNUALIZED PRE-TAX SAVINGS UP TO $170 MLN BY 2026 |
| 27.02 12:39 | dpa-AFX: *PERRIGO TO CUT ABOUT 6% OF ITS JOBS |
| 27.02 12:37 | dpa-AFX: *PERRIGO EXPECTS FY ADJ EPS TO BE $2.50-$2.65; ORGANIC NET SALES 1.0%-3.0% |
| 27.02 12:35 | dpa-AFX: *PERRIGO Q4 LOSS $32.3 MLN VS LOSS $23.6 MLN PRIOR YEAR |
| 27.02 12:35 | dpa-AFX: Perrigo Company plc Q4 Earnings Summary |
| 27.02 12:35 | dpa-AFX: *PERRIGO Q4 LOSS/SHR WIDENS TO $0.24 FROM $0.17 PRIOR YEAR |
| 27.02 12:33 | dpa-AFX: *PERRIGO Q4 NET SALES $1.2 BLN UP 0.1% FROM PRIOR YEAR QUARTER; ORGANIC NET SALES DECREASE 0.6% |
| 27.02 12:32 | dpa-AFX: *PERRIGO Q4 ADJ EPS $0.86, INCREASE OF 14.7% FROM LAST YEAR |
| 26.02 22:32 | dpa-AFX: *PERRIGO COMPANY PLC (PRGO) DECLARES QUARTERLY DIVIDEND OF $ 0.276, RECORD DATE 3/8/2024 |
| 07.11 13:30 | dpa-AFX: Perrigo Q3 23 Earnings Conference Call At 8:30 AM ET |
|
|
